INTERNALLY VALIDATED PREDICTION OF SEVERE HEALTH UTILITY IMPAIRMENT AMONG ADULTS REPORTING DEPRESSION IN THE EU5
Author(s)
Sarah Bakiri, Master Degree, Leila Alaoui Sosse, Master Degree.
Oracle Life Sciences, Paris, France.
Oracle Life Sciences, Paris, France.
OBJECTIVES: To identify characteristics associated with severe health utility impairment and evaluate the performance of a parsimonious prediction model among adults reporting past-year depression in the EU5.
METHODS: Data were from the 2025 European National Health and Wellness Survey. Adults reporting depression during the previous 12 months were included. Severe health utility impairment was defined as an EQ-5D-5L EU index score in the lowest quartile of the study sample (<=0.508). Multivariable logistic regression evaluated clinically available predictors. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), 10-fold cross-validation, Brier score, and Hosmer-Lemeshow calibration test. Discrimination was compared with a PHQ-9-only model.
RESULTS: Among 386 adults reporting depression, 96 (24.9%) met criteria for severe utility impairment. The final complete-case model included 366 respondents, including 90 events. Higher depressive symptom severity (PHQ-9; OR=1.21 per point; 95% CI, 1.14-1.28; p<0.0001), higher body mass index (OR=1.09; 95% CI, 1.05-1.14; p<0.0001), anxiety (OR=2.10; 95% CI, 1.07-4.14; p=0.031), and antidepressant use (OR=2.41; 95% CI, 1.35-4.31; p=0.003) were independently associated with severe utility impairment. The final model showed good apparent discrimination (AUC=0.839; 95% CI, 0.791-0.887), with stable performance in 10-fold cross-validation (AUC=0.822; 95% CI, 0.772-0.873). Discrimination exceeded the PHQ-9-only model (AUC=0.794; 95% CI, 0.743-0.846; difference=0.045; p=0.013). Calibration was acceptable (Hosmer-Lemeshow p=0.491; Brier score=0.128).
CONCLUSIONS: A parsimonious model using PHQ-9, body mass index, anxiety, and antidepressant use identified severe utility impairment with good internally validated discrimination. These findings support feasible risk stratification among adults reporting depression.
METHODS: Data were from the 2025 European National Health and Wellness Survey. Adults reporting depression during the previous 12 months were included. Severe health utility impairment was defined as an EQ-5D-5L EU index score in the lowest quartile of the study sample (<=0.508). Multivariable logistic regression evaluated clinically available predictors. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), 10-fold cross-validation, Brier score, and Hosmer-Lemeshow calibration test. Discrimination was compared with a PHQ-9-only model.
RESULTS: Among 386 adults reporting depression, 96 (24.9%) met criteria for severe utility impairment. The final complete-case model included 366 respondents, including 90 events. Higher depressive symptom severity (PHQ-9; OR=1.21 per point; 95% CI, 1.14-1.28; p<0.0001), higher body mass index (OR=1.09; 95% CI, 1.05-1.14; p<0.0001), anxiety (OR=2.10; 95% CI, 1.07-4.14; p=0.031), and antidepressant use (OR=2.41; 95% CI, 1.35-4.31; p=0.003) were independently associated with severe utility impairment. The final model showed good apparent discrimination (AUC=0.839; 95% CI, 0.791-0.887), with stable performance in 10-fold cross-validation (AUC=0.822; 95% CI, 0.772-0.873). Discrimination exceeded the PHQ-9-only model (AUC=0.794; 95% CI, 0.743-0.846; difference=0.045; p=0.013). Calibration was acceptable (Hosmer-Lemeshow p=0.491; Brier score=0.128).
CONCLUSIONS: A parsimonious model using PHQ-9, body mass index, anxiety, and antidepressant use identified severe utility impairment with good internally validated discrimination. These findings support feasible risk stratification among adults reporting depression.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
MSR246
Topic
Methodological & Statistical Research, Patient-Centered Research, Real World Data & Information Systems
Topic Subcategory
Artificial Intelligence, Machine Learning, Predictive Analytics
Disease
Mental Health (including addiction), No Additional Disease & Conditions/Specialized Treatment Areas